About 2017-08-23T09:38:30+00:00

Bioresorbable ImplantTechnologies

Why not make life a little easier by avoiding a surgical intervention – if you can?

CONTACT US FOR FURTHER INFORMATION

MEET OUR TEAM

The combination of clinical expertise in trauma and orthopaedic surgery and the know-how from research and engineering makes our team of experts as unique as it is.

FOUNDER

Assoz. Prof. Dr. Annelie-Martina Weinberg
Assoz. Prof. Dr. Annelie-Martina WeinbergCEO and Co-Founder
Annelie is a senior physician at the University Hospital Graz. In 2001, she was the first woman in the trauma surgery department to be awarded the habilitation. Besides that, she has made a name for herself by doing pioneering research in experimental biomechanics, molecular biology, and fracture healing in children, with a focus on absorbable implants. Her lifetime project is the realisation of the Laura Bassi Centre BRIC (Bioresorbable Implants for Children) at the Medical University of Graz: “I had been doing research on absorbable implants for children for several years – without sufficient financial support because the industry did not consider children worth investing in. But now things have changed. BRIC has given me the opportunity to hand down my knowledge to the next generation of researchers, to dedicate myself to scientific innovation.”Annelie Weinberg was the head of the BRIC project and is co-founder and CEO of BRI.TECH GmbH.
Ing. Heinz Moitzi
Ing. Heinz MoitziCo-Founder and Technical Advisor
Heinz has been working at AT&S (Austria Technologie & Systemtechnik AG) since 1981, initially as head of the mechanics and galvanics department, then as production and plant manager at Hinterberg. As the company’s manager and COO, he spent several years in Shanghai and then returned to the position of Vice President of Production; currently, he holds the position of CTO. His specific managerial responsibilities cover production, research and development, quality control, environment, safety, maintenance, and procurement.

MANAGEMENT

DI Dr. Johannes Andreas Eichler
DI Dr. Johannes Andreas EichlerCOO
Johannes was the scientific head of Annelie Weinberg’s research group BRIC and the deputy head of the department of preclinical imaging at the core facility for alternative biomodels and preclinical imaging at the Medical University of Graz before he assumed the responsibility for the operative business of BRI.Tech. Besides the medical studies he pursued from 2012 in the doctoral programme at the Laura Bassi Centre BRIC, Johannes has a master’s degree in telematics from the Graz University of Technology. Johannes is not only experienced in the management of research projects, but also in commercial marketing.
Univ.-Ass.in Nicole Grün, PhD.
Univ.-Ass.in Nicole Grün, PhD.Project management

Implants for Children

The main idea behind BRI.Tech is all about the treatment of broken bones in children. In dealing with fractures, the use of a stabilising implant is often unavoidable – and then, after a period of approximately six weeks, when bone healing is in a final state, a second operation is necessary to remove the implant from the growing skeleton. This, obviously, always constitutes a risk and might require another unpleasant hospital stay. Thus, developing a stable implant that dissolves naturally as soon as the bone is able to take over the load again is a major step towards avoiding pain and discomfort. All this can be achieved using natural elements only:

  • the endogenous elements magnesium, calcium, and zinc: essential for the human body and tolerated well in low doses

  • no discomfort due to screw heads under your skin

  • no complications caused by metal implants in the event of another fracture close to the implantation site

BRI.Tech Values

BRI.Tech’s intention is to avoid surgical interventions for implant removal, which helps to reduce costs for the European healthcare system.

Patients appreciate the fact that a surgical intervention using BRI.Screw will not be followed by a second one.

A lot of effort goes into quality control and certification according to ISO 10993, so that we can ensure highest standards of patient safety.